Influenza Vaccines Market Overview

The rising number of government investments is one of the significant drivers that help the Influenza Vaccines Market to grow in future. Influenza, commonly referred to as the flu, is a contagious viral infection of the respiratory system. It spreads through respiratory droplets produced when an infected person coughs or sneezes. Influenza can also spread through direct contact with the bodily fluids of an infected person. The influenza virus changes constantly, which is why it is important to get a flu vaccine every year.

Influenza Vaccines Market Dynamics

Influenza vaccines are made with three different influenza viruses: influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain. The increasing prevalence of influenza epidemics and seasonal outbreaks is expected to boost product sales over the forecast period.

Government support and surveillance of influenza vaccination at the national and global levels to monitor the supply, distribution, and administration of flu vaccines is a key driver of market growth. Additionally, rising investments by leading market players and government funding have facilitated the launch of therapeutically effective vaccines, further propelling the influenza vaccine market forward.

For More Insights Download Sample

The COVID-19 pandemic has impacted immunization camps and programs conducted by various healthcare organizations. However, flu vaccination rates have peaked during the pandemic due to government initiatives and public awareness campaigns, as well as the fear of contracting both flu and COVID-19.

Influenza Vaccines Market Segment Analysis

By Vaccine Type

• Quadrivalent
• Trivalent Vaccines

By Virus Type

• Type A Influenza Virus
• Type B Influenza Virus

By Age Group

• Children
• Adult

By Region

• North America
• South America
• Europe
• Asia Pacific
• Middle East and Africa

Major Companies Covered

CSL Limited, Abbott Laboratories, F.Hoffmann-La Roche Ltd, Emergent BioSolutions, GlaxoSmithKline PLC, Gamma Vaccines Pvt. Ltd, Merck & Co. Inc., Pfizer Inc., Sanofi Pasteur SA

About us

DataM Intelligence 4 Market Research is a premier market research and business consulting firm that empowers businesses with accurate, reliable, and real-time market data and insights across a wide range of industries. Established in 2017, we have collaborated with over 750 companies, delivering valuable market intelligence for more than 6000 markets. Our expertise, extensive industry coverage, and robust research methodology have earned us the trust of our clients, making us their go-to partner for market intelligence needs.

At DataM Intelligence, we provide comprehensive, insightful, and actionable market intelligence, helping businesses navigate complex market landscapes and make informed decisions. Our dedicated team of analysts and industry experts possess in-depth knowledge and experience in their respective fields, ensuring the highest levels of accuracy and data integrity. Choose DataM Intelligence for all your market research and business consulting needs and experience the difference our commitment to excellence can make for your business.

Media Contact

Company Name: DataM Intelligence
Contact Person: Sonal Kumari
Email: info@datamintelligence.com
Phone:+1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/